Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration

被引:12
|
作者
Visser, Annemiek [1 ]
Vrieling, Alina [1 ]
Murugesu, Laxsini [2 ]
Hoogerbrugge, Nicoline [3 ]
Kampman, Ellen [1 ,4 ]
Hoedjes, Meeke [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands
[2] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands
[4] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
COLORECTAL-CANCER; LIFE-STYLE; HEALTH BEHAVIORS; RISK; GUIDELINES; MANAGEMENT; HNPCC;
D O I
10.1371/journal.pone.0178205
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Lynch Syndrome (LS) mutation carriers are at high risk for various cancer types, particularly colorectal cancer. Adherence to lifestyle and body weight recommendations for cancer prevention may lower this risk. To promote adherence to these recommendations, knowledge on determinants of adherence in LS mutation carriers is needed. Therefore, this study aimed to identify determinants of adherence to lifestyle recommendations for cancer prevention in LS mutation carriers. Methods Five focus groups were conducted with DNA confirmed LS mutation carriers (n = 29). Transcripts were analyzed by thematic analysis, using the Health Belief Model (HBM) as a theoretical framework. Results Tolerance of an unhealthy lifestyle because of the desire to enjoy life and avoidance of LS dominating their life were most frequently reported as important barriers of adherence to the recommendations. Most important facilitators of adherence to the recommendations were enhancement of wellbeing and intolerance of unhealthy foods due to colon surgery. Conclusions This study provided a comprehensive overview of determinants of adherence to recommendations for cancer prevention. These determinants, of which some are typically and unique for LS mutation carriers, can be used to design a lifestyle intervention that meets the needs of LS mutation carriers.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Breast Cancer Prevention in BRCA1/2 Mutation Carriers: A Qualitative Review
    Fuller, Sarah
    Liebens, Fabienne
    Carly, Birgit
    Pastijn, Anne
    Rozenberg, Serge
    BREAST JOURNAL, 2008, 14 (06): : 603 - 604
  • [22] Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
    Engel, Christoph
    Loeffler, Markus
    Steinke, Verena
    Rahner, Nils
    Holinski-Feder, Elke
    Dietmaier, Wolfgang
    Schackert, Hans K.
    Goergens, Heike
    Doeberitz, Magnus von Knebel
    Goecke, Timm O.
    Schmiegel, Wolff
    Buettner, Reinhard
    Moeslein, Gabriela
    Letteboer, Tom G. W.
    Garcia, Encarna Gomez
    Hes, Frederik J.
    Hoogerbrugge, Nicoline
    Menko, Fred H.
    van Os, Theo A. M.
    Sijmons, Rolf H.
    Wagner, Anja
    Kluijt, Irma
    Propping, Peter
    Vasen, Hans F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) : 4409 - 4415
  • [23] Preventive dendritic cell vaccination in healthy Lynch syndrome mutation carriers
    Westdorp, H.
    Gorris, M. A. J.
    Boudewijns, S.
    Bisseling, T.
    de Goede, A. L.
    van Rossum, M. M.
    Ligtenberg, M. J. L.
    Schreibelt, G.
    Nagtegaal, I. D.
    Figdor, C. G.
    Gerritsen, W.
    Hoogerbrugge, N.
    de Vries, I. J. M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers
    Houlle, Solene
    Charbonnier, Francoise
    Houivet, Estelle
    Tinat, Julie
    Buisine, Marie-Pierre
    Caron, Olivier
    Benichou, Jacques
    Baert-Desurmont, Stephanie
    Frebourg, Thierry
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (08) : 887 - 892
  • [25] Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers
    Solene Houlle
    Françoise Charbonnier
    Estelle Houivet
    Julie Tinat
    Marie-Pierre Buisine
    Olivier Caron
    Jacques Benichou
    Stéphanie Baert-Desurmont
    Thierry Frebourg
    European Journal of Human Genetics, 2011, 19 : 887 - 892
  • [26] Immunoprevention Strategies for Colorectal Cancer in Lynch Syndrome Carriers
    Bowen, Charles M.
    Sinha, Krishna M.
    Vilar, Eduardo
    CANCER JOURNAL, 2024, 30 (05): : 352 - 356
  • [27] Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
    Baglietto, Laura
    Lindor, Noralane M.
    Dowty, James G.
    White, Darren M.
    Wagner, Anja
    Garcia, Encarna B. Gomez
    Vriends, Annette H. J. T.
    Cartwright, Nicola R.
    Barnetson, Rebecca A.
    Farrington, Susan M.
    Tenesa, Albert
    Hampel, Heather
    Buchanan, Daniel
    Arnold, Sven
    Young, Joanne
    Walsh, Michael D.
    Jass, Jeremy
    Macrae, Finlay
    Antill, Yoland
    Winship, Ingrid M.
    Giles, Graham G.
    Goldblatt, Jack
    Parry, Susan
    Suthers, Graeme
    Leggett, Barbara
    Butz, Malinda
    Aronson, Melyssa
    Poynter, Jenny N.
    Baron, John A.
    Le Marchand, Loic
    Haile, Robert
    Gallinger, Steve
    Hopper, John L.
    Potter, John
    de la Chapelle, Albert
    Vasen, Hans F.
    Dunlop, Malcolm G.
    Thibodeau, Stephen N.
    Jenkins, Mark A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03): : 193 - 201
  • [28] Aspirin and colorectal cancer prevention in Lynch syndrome
    Chan, Andrew T.
    Lippman, Scott M.
    LANCET, 2011, 378 (9809): : 2051 - 2052
  • [29] Adherence to extracolonic cancer screening in Lynch syndrome kindreds
    Stadler, Z. K.
    Stern, R.
    Devlin, V.
    Glogowski, E.
    Kauff, N.
    Offit, K.
    Hurley, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Patterns and determinants of adherence to colorectal cancer primary and secondary prevention recommendations in the BC Generations Project
    Sweeney-Magee, Molly
    Gotay, Carolyn
    Karim, Mohammad Ehsanul
    Telford, Jennifer
    Dummer, Trevor
    HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE, 2022, 42 (02): : 79 - 93